Donate

A Real Life Experience Using A C-11 Choline Scan To Combat A Prostate Cancer Recurrence

In response to the post I wrote about Choline C-11 on December 11, 2013 Choline C-11 A Second Shot To Halt the Cancer After Primary Treatment Failure one of our group members contact me and shared that he was scheduled to have a similar scan. I asked if he would be willing to share his [...]

PET/MR Imaging More Efficacious for Mapping Recurrent Prostate Cancer

Approximately one third of all men diagnosed and treated for prostate cancer will experience a recurrence of their prostate cancer! This is a shocking number, but it is a true number. It does not matter what the treatment a man has, the statistic holds up across all treatments. The first sign of a problem, a [...]

Stat5 as a Potential Biomarker for a Prostate Cancer Recurrence Post Surgery

Once you have had primary treatment for prostate cancer you must continue to actively monitor your PSA until you die. There is no cure; at least you should never assume that you have been cured because 1/3 of all men who have treatment will have a recurrence. What treatment you have does not matter, statistically [...]

A Great Stride In PET Imaging, But Not A Panacea – C11 Choline For Diagnosing Recurrent Prostate Cancer

The FDA has approved c11 choline Injection, a Positron Emission Tomography (PET) imaging agent, for use in men to detect prostate cancer recurrences and to locate specific body sites for follow-up tissue sampling, testing and treatment. The indicated use for c11 choline injection is men with elevated prostate specific antigen (PSA) levels after earlier primary [...]

Long-Term Overall Survival & Metastasis-Free Survival Post Surgery After A Biochemical Recurrence of Prostate Cancer

Researchers at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and the Walter Reed Army Medical Center evaluated metastasis-free survival (MFS) and overall survival (OS) among men with a biochemical reoccurrence (PSA only) of prostate cancer after having received a radical prostatectomy but did not receive additional therapy until developing metastases […]

Malecare’s Advanced Prostate Cancer Program

Malecare is pleased to announce several new enhancements to our Advanced Prostate Cancer Program as well as the release of our new Advanced Prostate Cancer Kit which includes our newest publication: RECURRENT PROSTATE CANCER A Working Document for Men with Recurrent Prostate Cancer For many years, Malecare has been the leader in the fight against [...]

PET/CT Scans May Help Detect Recurring Prostate Cancer Earlier

The September issue of The Journal of Nuclear Medicine published a study that shows that positron emission tomography (PET)/computer tomography (CT) scans using the imaging agent choline could detect recurring prostate cancer sooner than conventional imaging technologies in some patients who have had their prostates surgically removed. Men who elect to have a radical prostatectomy [...]

How a Prostate Cancer Recurrence Is Currently Dealt With – Salvage Methods For Recurrent Prostate Cancer After Failure Of PrimaryRadiotherapy

The authors of a recent study from the Duke Prostate Center and Division of Urology, Department of Surgery, Duke University Medical Center, Durham, N.C. and the Department of Urology, Kitasato University School of Medicine, Kanagawa, Japan reviewed the current salvage methods for treating recurrent local recurrent prostate cancer after primary radiotherapy (RT). They used a [...]

Salvage Radical Prostatectomy for Recurrent Prostate Cancer after Radiation Therapy.

I often discuss the use of salvage radiation after surgery has failed and the PSA begins to rise. Although often mentioned, but seldom used, men who fail radiation as a primary treatment can also benefit from salvage surgery. When I first was deciding what to use as my primary treatment modality I was led to [...]

Clinical Trial Using HIFU for Men with Advanced Prostate Cancer After Radiation Failure

HIFU (high-intensity focused ultrasound) is one of the newer treatments for prostate cancer. Although not yet approved in the United States it has received a lot of press and growing popularity as a primary treatment option. There are a number of European countries already using it as a regular treatment modality and there are a [...]

Go to Top